Counterpoints: Do Patients With Multiple Myeloma Need Maintenance Treatment?

By Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 Multiple myeloma…

read more

KIIS Cares Interview

What: Myeloma is a disease in your bone marrow. Inside your bone marrow are the…

read more

IMBCR Identifies New Treatments for Myeloma in 2015!

First, we have made much progress on our new protein marker called B-cell maturation antigen…

read more

I Have WHAT? An Interview With Patient Advocate Debra Berenson

Interview with Debra Berenson, myeloma patient advocate, wife of myeloma expert Dr. James Berenson, and…

read more

To Transplant or Not To Transplant in Multiple Myeloma

Clinical Advances in Hematology & Oncology [button style=”download” link=”https://www.hematologyandoncology.net/files/2014/05/ho0514_counter1.pdf” color=”teal”]Download Paper[/button] Authors: James R. Berenson,…

read more

Advances in the Management of Multiple Myeloma

James R Berenson, MD,abc Tanya M Spektor, PhD,c and James Wang, MDab aInstitute for Myeloma…

read more

Replacement of Bortezomib with Carfilzomib for Multiple Myeloma Patients Progressing from Bortezomib Combination Therapy

J R Berenson1,2,3, J D Hilger2, O Yellin2, R Dichmann4, D Patel-Donnelly5, R V Boccia6, A Bessudo7, L Stampleman8, D Gravenor9, S Eshaghian10, Y Nassir11, R…

read more

Results of CHAMPION-1: A Phase 1/2 Study of Weekly Carfilzomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma

James R. Berenson, Alan Cartmell, Alberto Bessudo, Roger M. Lyons, Wael Harb, Dimitrios Tzachanis, Richy…

read more

A Phase 2 Study of Accelerated Elotuzumab Infusion, over Less than 1 Hour, in Combination with Lenalidomide and Dexamethasone, in Patients with Multiple Myeloma

Abstract Elotuzumab, an immunostimulatory SLAMF7-targeting monoclonal antibody, induces myeloma cell death with minimal effects on…

read more

Levels of Uninvolved Immunoglobulins Predict Clinical Status and Progression Free Survival for Multiple Myeloma Patients

Abstract Multiple myeloma (MM) is characterized by the enhanced production of the same monoclonal immunoglobulin…

read more